09:20am Berenberg Calls for More Acquisitions from Sanofi; Estimates Updated MT
05-06 Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports RE
05-06 Sanofi supports AlphaDetect to accelerate detection of Alpha-1 RE
05-06 Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review - Stat News RE
05-05 SANOFI : JP Morgan sticks Neutral ZD
05-05 Sanofi expands its footprint in Canada Zonebourse
05-04 For final dividend FA
05-04 Sanofi Plans $216 Million AI Center Expansion in Toronto MT
05-04 Sanofi invests $294M to expand AI center of excellence in Toronto RE
05-04 Sanofi Expands Artificial Intelligence Center of Excellence in Toronto CI
05-04 Morgan Stanley Downgrades Sanofi to Equalweight From Overweight, Adjusts Price Target to $52 From $55 MT
04-30 Regeneron's Eylea Franchise on 'Solid Footing' Despite HD Sales Miss in Q1, Oppenheimer Says MT
04-29 Regeneron beats quarterly estimates on Dupixent demand; shares fall on Eylea weakness RE
04-29 Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi GL
04-29 Sanofi Approves Ordinary Annual Dividend, Payable on May 7, 2026 CI
04-29 Sanofi Announces Board and Committee Changes CI
04-29 Regeneron beats quarterly results estimates on strong Dupixent demand RE
04-28 Sanofi remains flat despite positive outlook from Oddo BHF Zonebourse
04-28 SANOFI : Bernstein reiterates its Buy rating ZD
04-28 SANOFI : Buy rating from Deutsche Bank ZD
04-27 Sanofi in the red as UBS maintains Neutral stance Zonebourse
04-27 Sanofi's Cenrifki recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses AQ
04-27 SANOFI : UBS remains Neutral ZD
04-27 Sanofi Prices EUR2.3 Billion Multi-tranche Offering of Fixed-rate Notes MT
04-27 Sanofi prices 2.3 billion euro bond issue Zonebourse
No results for this search